This particular stock has fallen out of favor once again, but don’t assume this means Wall Street has finally had it with this early-stage artificial intelligence… Read More »This $8 Stock Could Be Your Ticket To Millionaire Status
With markets choppy and growth names getting hammered into May, the sub-$20 corner of the market is suddenly worth a second look. Two of the… Read More »2 High-Growth Stocks Under $20 That Make For Screaming Buys Right Now
Ondas Holdings (ONDS) reported Q1 2026 revenue of $50.1 million, up 1,065% year-over-year from $4.3 million. The company beat analyst estimates of $39.4 million and its own… Read More »Ondas Holdings Just Posted 1,065% Revenue Growth. Here Is Why This Is Just The Beginning
For this article, we screened for dividend companies with market caps between $50 million and $300 million. We identified companies with stable dividend policies. Finally,… Read More »12 Best Micro-Cap Dividend Stocks To Buy Now
The allure of low stock prices is obvious, but also potentially dangerous. A lot of stocks with single-digit stock prices are there for a reason.… Read More »3 Stocks Under $10 To Buy In May
Clinical-stage biotech is one of the few corners of the market where a sub-$30 share price genuinely matters: small-cap oncology names can re-rate violently around… Read More »Buy These 3 Clinical-Stage Biotechs Under $30 With Solid Cash Runways
The software market has long been the foundation of the modern-day digital economy, but investors are now paying closer attention than ever. As enterprises adopt… Read More »9 Best Software Infrastructure Stocks To Buy Now
The biggest payoff from investing in stocks often comes years down the road, when companies you’ve invested in have grown larger and become more valuable.… Read More »3 Growth Stocks That Could Generate 10X Returns
Every time a major tech company reports a marginally-less-than-perfect quarter, the ‘AI is a bubble’ crowd gets louder. They cite ‘diminishing returns’ and ‘overcapacity’ —… Read More »The AI Infrastructure Stocks No One Is Watching
Boston Scientific trades around $61, with analyst price targets ranging from $69 (conservative) to $124 (optimistic), implying substantial upside. Abbott Laboratories trades near $95 against an optimistic target… Read More »2 Healthcare Stocks At 52-Week Lows That Analysts Still Love